February 4, 2019
EyePoint Pharmaceuticals announces launch of YUTIQ
EyePoint Pharmaceuticals announces U.S. commercial launch of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg.
February 4, 2019